Share Facebook Twitter Pinterest Email Copy Link Tylenol-maker Kenvue on Thursday beat Wall Street estimates for first-quarter revenue and profit helped by strong sales in its skin health and beauty brands. earnings mergers-acquisitions
US Fashion & Lifestyle Tapestry Lifts Annual Targets, Beats Quarterly Estimates on Strong Demand for Tabby BagsMay 7, 2026